C

Human pharmaceuticals for the treatment of neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, or skeletal muscle weakness